Other
Supplementary Table 1 from Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Abstract
Authors
Winquist E; Hotte SJ; Chi K; Sridhar S; Ellard S; Ong M; Iqbal N; Salim M; Emmenegger U; Gingerich JR
Publication Date
January 6, 2025
DOI
10.1158/1078-0432.28141743